The effect of biphasic positive airway pressure (Bi-PAP) at individualized pressures on the postoperative pulmonary recovery of morbidly obese patients (MOP) undergoing open bariatric surgery (OBS) and possible placebo device-related effects (sham-Bi-PAP) were investigated.
In the present study the effect of Bi-PAP on the postoperative respiratory function and related complications of MOP undergoing OBS through a randomized sham-controlled design was investigated. Bi-PAP was applied at individualized pressures in order to optimize respiratory support and sham Bi-PAP was also used in order to neutralize possible placebo device related effect and researcher related bias. The investigators hypothesized that the use of Bi-PAP at individualized pressures in MOP undergoing OBS, ameliorates postoperative respiratory function as well as diminishes related pulmonary complications, postoperative pain and duration of hospitalization. Primary endpoints were the difference in pre- and postoperative measurements of certain pulmonary function parameters (forced expiratory volume at one second (FEV1), forced vital capacity (FVC), peak expiratory flow rate (PEFR) and oxygen saturation by pulse oximetry (SpO2) and the incidence of certain pulmonary complications postoperatively (hypoxemia, atelectasis, lower respiratory tract infections). Secondary endpoints were postoperative pain and days of hospitalization.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
48
The Bi-PAP system combines inspiratory support-IPAP (inspiratory positive airway pressure) with expiratory support-EPAP (expiratory positive airway pressure) and has been used, with good results, in a number of different clinical conditions such as COPD, respiratory failure due to neuromuscular disease, cardiogenic pulmonary edema and immediately post-operatively with pro-phylactic purpose.
Sham Bi-PAP was created by introducing a "hole" at the connection of the mask with the spiral tube of the conventional Bi-PAP system. By doing so, the applied pressure by sham Bi-PAP was constant and equal to 2 cm H2O.
Forced Expiratory Volume at One Second (FEV1) Difference
difference in FEV1 value measured by spirometry pre- and post-operatively
Time frame: 24 h before surgery and at 24, 48 and 72 h post-operatively
Forced Vital Capacity (FVC) Difference
difference in FVC value measured by spirometry pre- and post-operatively
Time frame: 24 h before surgery and at 24, 48 and 72 hours post-operatively
Peak Expiratory Flow Rate (PEFR) Difference
difference in PEFR value measured by spirometry pre- and post-operatively
Time frame: 24 h before surgery and at 24, 48 and 72 hours post-operatively
SpO2 Difference
difference in SpO2 value measured by spirometry pre- and post-operatively
Time frame: 24 h before surgery and at 24, 48 and 72 hours post-operatively
Number of Participants With Hypoxemia
occurrence of hypoxemia, considered as SpO2\<90%, post-operatively
Time frame: At 24, 48 and 72 hours post-operatively
Number of Participants With Atelectasis
occurrence of atelectasis as defined by chest X-ray (CXR) post-operatively with CXR before surgery as baseline
Time frame: At 24, 48 and 72 hours post-operatively
Post-operative Pain
Intensity of pain was assessed post-operatively by Numerical Rating Scale (NRS) (0-10, 0=no pain, 10=worst pain imaginable)
Time frame: right before spirometry, at 24, 48 and 72 h post-operatively
Days of Hospitalization
duration of hospitalization, calculated by discharge date minus admission date
Time frame: From day of admission to day of discharge from the hospital
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.